Add to ORKGdose reduction in type 2 diabetes mellitus patients: An open level comparative prospective stud
Background: Patients with type 2 diabetes are often obese and require large dose of insulin to achie...
OBJECTIVES: To examine pioglitazone as add-on to metformin and insulin secretagogues in patients wit...
In this multicentre, randomized, double-blind, controlled, parallel-group trial, 103 patients with t...
Pioglitazone increases the insulin sensitivity of peripheral tissues andmayprovide analternative fir...
Pioglitazone increases the insulin sensitivity of peripheral tissues and may provide an alternative ...
The aim of the study was to compare the effects of the addition of sitagliptin or metformin to piogl...
The aim of the study was to compare the effects of the addition of sitagliptin or metformin to piogl...
Type 2 diabetes is treated in a stepwise manner, progressing from diet and physical activity to oral...
none12BACKGROUND: Metformin is considered the gold standard for type 2 diabetes treatment as monot...
BACKGROUND: While metformin is the first line treatment in type 2 diabetes, the best way to escalate...
OBJECTIVE — Traditional cardiovascular risk factors (CVRF) only partly explain the exces-sive risk o...
Metformin is considered the gold standard for type 2 diabetes treatment as monotherapy and in combin...
Double Blind parallel randomized clinical trial to demonstrate the effects of metfomin in insulin tr...
OBJECTIVE — Pioglitazone, metformin, and gliclazide lower HbA1c and fasting plasma glu-cose in patie...
In this multicentre, randomized, double-blind, controlled, parallel-group trial, 103 patients with t...
Background: Patients with type 2 diabetes are often obese and require large dose of insulin to achie...
OBJECTIVES: To examine pioglitazone as add-on to metformin and insulin secretagogues in patients wit...
In this multicentre, randomized, double-blind, controlled, parallel-group trial, 103 patients with t...
Pioglitazone increases the insulin sensitivity of peripheral tissues andmayprovide analternative fir...
Pioglitazone increases the insulin sensitivity of peripheral tissues and may provide an alternative ...
The aim of the study was to compare the effects of the addition of sitagliptin or metformin to piogl...
The aim of the study was to compare the effects of the addition of sitagliptin or metformin to piogl...
Type 2 diabetes is treated in a stepwise manner, progressing from diet and physical activity to oral...
none12BACKGROUND: Metformin is considered the gold standard for type 2 diabetes treatment as monot...
BACKGROUND: While metformin is the first line treatment in type 2 diabetes, the best way to escalate...
OBJECTIVE — Traditional cardiovascular risk factors (CVRF) only partly explain the exces-sive risk o...
Metformin is considered the gold standard for type 2 diabetes treatment as monotherapy and in combin...
Double Blind parallel randomized clinical trial to demonstrate the effects of metfomin in insulin tr...
OBJECTIVE — Pioglitazone, metformin, and gliclazide lower HbA1c and fasting plasma glu-cose in patie...
In this multicentre, randomized, double-blind, controlled, parallel-group trial, 103 patients with t...
Background: Patients with type 2 diabetes are often obese and require large dose of insulin to achie...
OBJECTIVES: To examine pioglitazone as add-on to metformin and insulin secretagogues in patients wit...
In this multicentre, randomized, double-blind, controlled, parallel-group trial, 103 patients with t...